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ABSTRACT  A novel peptide mapping approach  has been used to map sites of charge modifi- 
cation to major structural domains of regulatory subunit (R) of type I cAMP-dependent protein 
kinase from $49 mouse lymphoma cells. Proteolytic  fragments of crude,  radiolabeled  R were 
purified by cAMP affinity chromatography  and displayed by two-dimensional  polyacrylamide 
get electrophoresis.  [3SS]methionine-labeled  peptides  containing  sites of  mutation  or  phos- 
phorylation exhibited charge heterogeneity  attributable  to the modification.  Phosphate-con- 
taining fragments were also labeled with [32p]orthophosphate to confirm their phosphorylation. 
Major fragments from [35S]methionine-labeled $49 cell R corresponded  in size to carboxyter- 
minal cAMP-binding fragments reported  from  proteolysis  of purified type I Rs from various 
mammalian species; additional  fragments were also visualized. End-specific markers in Rs from 
some mutant $49 sublines confirmed that cAMP-binding fragments extended  to the carboxy- 
terminus  of  R.  Aminoterminal  endpoints  of fragments could  be  deduced,  therefore,  from 
peptide molecular  weights. Clustering of proteolytic cleavage sites within the "hinge-region" 
separating aminoterminal  and carboxyterminal  domains of R permitted  high resolution  map- 
ping in this region: the endogenous  phosphate and a "phenotypically-silent" electrophoretic 
marker mutation fell within a 2.5-kdalton  interval at its aminoterminal  end. On the other hand, 
K~ mutations  that  increase the apparent  constant for activation  of kinase by cAMP  mapped 
within the large cAMP-binding region of R. A map of charge density  distribution  within the 
hinge-region  of R was constructed  to facilitate  structural  comparisons  between  Rs from $49 
cells and from other mammalian sources. 
As the intraceUular transducers for hormones acting through 
elevation of cAMP,  cAMP-dependent protein kinases play 
central roles in  the  regulation  of animal  cell  metabolism. 
Accordingly, these enzymes have been subjected to intensive 
structural, functional, and metabolic study, cAMP-dependent 
protein kinases have tetrameric structures consisting of two 
catalytic subunits (Cs t) and a regulatory subunit (R) dimer ( 1, 
2). Two major classes of mammalian kinases,  designated as 
types I  and  lI,  appear to differ only in  Rs  (2-4).  Kinase 
holoenzyme is inactive; activation proceeds by a concerted 
reaction in which cAMP binds to holoenzyme releasing active 
J Abbreviations used in this paper: C, catalytic subunit; R, regulatory 
subunit. 
Cs and an R dimer complexed with cAMP (2, 5, 6). R  has 
two sites for binding cAMP (7-9) as well as sites for R dimer 
formation and for interaction with C. Furthermore, confor- 
mational interaction between cAMP-binding and C-binding 
regions of R  is suggested  by the concerted mode of kinase 
activation and by studies showing structural alterations in R 
that accompany binding of cAMP (5, 6,  10, 11). 
Native Rs purified from a  variety of mammalian tissues 
exhibit similar structures with proteolytically-sensitive  "hinge- 
regions" extending from ~25 to 30% of the way from ami- 
noterminal to carboxyterminal ends of the molecules (7,  8, 
12). The hinge-region divides R into an aminoterminal do- 
main involved in dimer association and a  carboxyterminal 
domain containing cAMP-binding sites (7, 8,  12); the hinge- 
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(7, 8,  13,  14). Anautophosphorylation  site in R,  maps to the 
carboxyterminal end of the hinge-region (13,  15), and phos- 
phorylation at this site reduces both the proteolytic suscepti- 
bility  of R  (13)  and  the  affinity  of  R  for  C  (16-18).  An 
homologous region in RI can be phosphorylated with purified 
cGMP-dependent protein kinase causing reductions in bind- 
ing of both cAMP  and C  (l 9-2 l), but this phosphorylation 
does  not  occur  under  physiological  conditions  (21).  Addi- 
tional phosphorylation sites have been found in the amino- 
terminal end of bovine R,: serines 74 and/or 76 are phospho- 
rylated in vivo to a  considerable extent and can be nhost~ho- 
rylated in vitro by casein kinase II (glycogen synthase kinase 
5; 22, 23); serines 44 and 47 can be phosphorylated in vitro 
by glycogen synthase kinase 3 and are phosphorylated in vivo 
to a  small extent (23).  R~  is not phosphorylated in vitro by 
glycogen  synthase  kinases  3,  4,  or  5  or  by  phosphorylase 
kinase (23), but it is phosphorylated to a  significant extent in 
vivo  at  a  site  that  has  not  yet  been  reported  (21,  24,  25). 
Endogenous phosphorylation does not affect the ability of RI 
to bind either cAMP or C  subunit (21). 
Mutants  with  lesions  affecting  cAMP-dependent  protein 
kinase have been isolated  from cultures of $49  mouse lym- 
phoma  cells by  clonal  growth  in  the  presence  of dibutyryl 
cAMP (26-28); wild-type cells are killed by this analog (29). 
In some such mutants the apparent constant for activation of 
kinase by cAMP  is increased to 5  to 20 times that for wild- 
type  kinase (27,  28).  cAMP-dependent protein  kinase  from 
$49  ceils  is  mostly  of the  type  I  isozyme,  and  these  "Ka" 
mutants carry structural mutations in R~ (24,  30,  31). Many 
Ka mutations cause changes in R~ charge that provide electro- 
phoretic markers for the mutational change and reveal $49 
cells to be diploid  for  Rm genes (24).  A  cAMP-sensitive $49 
subline that  carries  an  electrophoretic  marker  mutation  in 
one  R  allele  has  also  been  described  (32).  In  $49  cells,  R 
phosphorylation is at a  single serine residue and is modulated 
in vivo by both cAMP and mutations affecting kinase activity 
(24, 32, 33). 
In the present report, sites of phosphorylation and mutation 
in $49 cell R  are mapped to structural domains of the protein 
by  studying  cAMP-binding  fragments  from  wild-type  and 
mutant cells.  Procedures used for analysis of purified Rs (7, 
8,  12-14) have been modified for use with crude preparations 
from  radiolabeled  cells,  cAMP-affinity  columns  (34)  were 
used  to  purify  cAMP-binding  fragments,  and  two-dimen- 
sional polyacrylamide gel electrophoresis (35) was used both 
to resolve R  fragments from contaminating peptides and to 
reveal charge heterogeneity attributable to either phosphoryl- 
ation or mutations. Sites of endogenous phosphorylation and 
ofa phenotypically-silent marker allele mutation (above) were 
mapped  to  a  small  region  at  the aminoterminal end of the 
hinge-region of R. Several K~ mutations fell within the cAMP- 
binding region of R. Subsequent reports will present methods 
for mapping mutations within the carboxyterminal domain 
of R  with greater precision (R. A. Steinberg, submitted man- 
uscripts). 
MATERIALS  AND  METHODS 
Chemicals and Radiochemicals:  Ovalbumin (albumin, egg, 5 x 
crystalline) and thermolysin  were obtained  from Calbiocbem-Behring Corp. 
(San Diego, CA), and a-chymotrypsin was obtained from Miles Laboratories, 
Inc. (Elkhart, IN). N*-(2-aminoethyl)-cAMP Scpharose (34) and control Scph- 
arose were prepared using CNBr-activated Scpharose 4B from Pharmacia Fine 
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Chemicals  (Piscataway, NJ),  as  described  previously (33). [35S]methionine 
(>900 Ci/mmol) and ACS scintillation mixture were obtained from Amersham 
Corp. (Arlington Heights, IL), and [32P]orthopbosphate  (carrier-free in water) 
was from New England Nuclear (Boston, MA). X-ray film and photographic 
chemicals were from Eastman Kodak (Rochester, NY), and intensifying screens 
were from E. I. Du Pont de Nemours & Co. (Wilmington, DE). Chemicals for 
solutions used in extraction and purification of R and for two-dimensional gel 
electrophoresis were obtained as reported previously (33). 
Cell  Culture:  Clonal sublines of $49.1  mouse lymphoma cells (36) 
were grown in suspension culture as described previously (37). The wild-type 
subline 24.3.2 was obtained by serial subeloning of $49.1 under nonselective 
conditions (26); the allelically-marked cAMP-sensitive subline U36 was derived 
from a thymidine kinase-negative subline of $49.1 that was mutagenized with 
ethyl methanesulfonate and selected for resistance to 10 mM ouabain (32). K~ 
mutant subline U200.65 was selected from a population of 24.3.2 mutagenized 
with N-methyI-N'-nitro-N-nitrosoguanidine  (24, 28); K. mutants U36.B1.R5 
and U36.B2.R1  were selected from  freshly subcloned  populations  of U36 
without mutagenesis.  2 
Radiolabeling and Preparation of Cell Extracts:  Concentrated 
suspensions of cells in low methionine or low phosphate media were labeled 
with [3SS]methionine  or [32p]orthophospbate as described elsewhere (38, 39) 
except that, for the experiments of Figs. 5 and 6, cells were concentrated to 
5 x  106 per ml instead of 2.5 x  106 per ml, and preincubation  times were 
reduced from 2 to 1 h. [3SS]methionine  labeling was for 3 h at 100 #Ci per ml 
(Figs. 1 and 3), 5 h at 60 ~Ci per ml (Figs. 2 and 4), or 4 h at 75 uCi per ml 
(Figs. 6 and 7); 32Pi labeling was for 6 h at 100 uCi per ml. After labeling, cells 
were harvested by centrifugation and washed once with ice-cold PBS (containing 
2 mM L-methionine for aSS-labeled cells); saline was aspirated; and cells were 
frozen in dry ice and stored at -70°C. Extracts were prepared by dissolving cell 
samples at a  concentration  of 1.67 × 106 cells per ml in extraction  buffer 
containing  10 mM Tris-HC1, pH  7.5, 2 mM dithiothreitol,  2  mM EDTA 
(ethylenediamine tetraacetate), 2 mM L-methionine, and 0.5 % wt/vol Nonidet 
P-40 to give protein concentrations of ~5 mg per ml. Extracts were clarified 
by centrifugation for 5 min at 8 to 10,000 g in a Fisher microcentrifuge (Fisher 
Scientific Co., Pittsburgh, PA). (For Figs. 5 and 6 centrifugation was for 10 min 
at about 160,000 g in a Beckman airfuge centrifuge [Beckman Instruments, 
Inc., Fullerton, CA], but this modified procedure did not appreciably affect R 
purification.) 
Affinity  and Control Sepharose  Purifications:  Undigested or 
proteolyzed cell extracts were loaded onto 20-ul columns of N~-(2-aminoethyl)  - 
cAMP  Sepharose or control  Sepharose at room  temperature  as described 
elsewhere (33, 39). After  loading, columns  were washed successively with 
portions of "starting buffer" containing l0 mM 4-morpholineethanesulfonate, 
pI4 6.6, l mM dithiothreitol, 2 mM EDTA,  1 mM L-methionine, 0.3 mg per 
ml ovalbumin, 0.5% wt/vol Nonidet P-40; starting buffer with the addition of 
l  M sodium chloride; starting buffer; and starting buffer lacking methionine 
and ovalbumin (24, 33, 39). Bound radioactivity was eluted with gel sample 
buffer; 2-5-~1 portions were subjected to scintillation counting in 6 ml ACS 
scintillation mixture; and samples were stored frozen at -70°C as described 
elsewhere (24, 39). 
Thermolysin  and  Chymotrypsin  Proteolysis:  l  mg/ml-stock 
solutions ofthermolysin in water and chymotrypsin in 1 mM hydrochloric acid 
were stored in small portions at -70"C. For proteolysis in cell extracts, proteases 
were diluted with a 5 mg/ml-solution ofovaibumin in water, then 10-~1  portions 
of the diluted proteases were added to mixtures of 10-td cell extracts and 5 ~tl 
0.2 M sodium bicarbonate.  Mixtures were incubated  for  1 h at 30"C, then 
subjected to affinity or control Scpharose purification as above. Concentrations 
of proteases in incubation mixtmxs were 8 ~g per ml (Figs. 3 and 4) or 20 #g 
per ml (Fig. 2, a and b) to give ratios of protease to protein of ~ 1:500 or 1:200. 
For column proteolysis, extracts were loaded onto affinity or control Sepharose 
columns,  and columns  washed as above through the second set of starting 
buffer washes. Columns  were then washed twice with 0.2 ml of "digestion 
solution" containing 50 mM sodium bicarbonate,  1 mM dithiothreitol,  1 mg 
per ml ovalbumin, and 0.5% wt/vol Nonidet P-40; washed twice with 0.2 ml 
of digestion solution containing, in addition, thermolysin at 2 ug per ml (Fig. 
2, c and d) or chymotrypsin at 2.5 #g per ml (Fig. 6); and incubated with a 
third portion  of protease-containing solutions for  1 h at room  temperature. 
Columns were then washed twice with 0.2 ml starting buffer and twice with 
0.2 ml starting buffer lacking methionine and ovalbumin  before eluting as 
above. Eluted samples were counted and stored as above. 
Two-dimensional Polyacrylamide Gel Electrophoresis:  The 
O'Farrell  two-dimensional gel procedure  (35) was  used with  modifications 
2 Details of the isolation and characterization of these mutants will 
be presented in a subsequent report. 
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amide. To calibrate peptide molecular weights in the two-dimensional gel 
patterns, samples  of ~4C-labeled  proteins from bacteriophage  T4-infected  Esch- 
erichia coli (40) were loaded  on selected  second  dimension  gels  in wells  adjacent 
to first dimension gels; calibration curves from the bacteriophage T4 proteins 
were adjusted for cellular actin (Mr 43,000) to give an apparent subunit 
molecular weight of 49,000 for R. All gel patterns are shown with the acidic 
FIGURE 1  Two-dimensional gel electro- 
phoresis  patterns  of  affinity-purified  R 
from  wild-type  and  mutant  $49  cells. 
Cells were labeled with [~SS]methionine, 
extracts prepared,  and portions purified 
on  N6-(2-aminoethyl)-cAMP  Sepharose 
as described in Materials and Methods. 
2 x  104  cpm  of  the  purified  samples 
were subjected  to two-dimensional gel 
electrophoresis, and  autoradiograms  of 
dried gels were exposed for 29 d. (a) R 
from wild-type subline 24.3.2; (b) R from 
the allelically-marked subline U36;  (c)  R from  K~  mutant subline 
U200.65.  Arrowheads indicate positions of the various forms  of R 
as described in the text. 
end of the isoelectric  focusing  dimension at the fight and the low molecular 
weight region of the SDS gel dimension at the bottom. 
Autoradiography and Fluorography:  For Figs. 1, 3, and 4, 35S- 
labeled peptides  were detected by direct autoradiography  of dried gels;  autora- 
diography of 32p-labeled peptides (Fig. 4, b and c) was enhanced by using 
Lightning-Plus  intensifying  screens  as described  previously  (33). For the gels  of 
Figs. 2, 5, and 6, 35S-labeled  species were detected by the fluorographic  proce- 
dure of Bonner and Laskey  (4 l), 
RESULTS 
Fig.  1  shows  portions  of two-dimensional  gel  patterns  of 
affinity-purified R  from [3SS]methionine-labeled $49 cells to 
illustrate the charge heterogeneity in R~ caused by phospho- 
rylation and mutation. The positions of nonphosphorylated 
(left)  and  phosphorylated  (right)  forms  of wild-type  R  are 
indicated by downward-pointing arrowheads; corresponding 
forms of mutant Rs are indicated by upward-pointing arrow- 
heads. Under the labeling conditions used for this experiment 
and for the other experiments described in this report, ~90% 
of labeled R  in wild-type ceils (Fig.  I a) was in the phospho- 
rylated form (33). In subline U36 (Fig.  1 b), which has a wild- 
type phenotype (32), recoveries and phosphorylations of wild- 
type  and  mutant  Rs  were  approximately  equal.  In subline 
FIGURE 2  Two-dimensional gel patterns  of 
affinity  or  control  Sepharose-bound  ther- 
molytic  peptides  from  [35S]methionine-la- 
beled wild-type  cells.  Wild-type  $49  cells 
were labeled with [3SS]methionine, extracts 
prepared,  and portions digested  with ther- 
molysin directly or after binding to columns 
as  described  in  Materials  and  Methods. 
5 x  104 cpm of column-purified samples for 
a and b and 2 x  104 cpm for c and d were 
subjected  to  two-dimensional electropho- 
resis; fluorographic exposures were for 6 d. 
(a) Affinity Sepharose-bound,  and (b)  con- 
trol Sepharose-bound,  peptides from a cell 
extract  proteolyzed  with  thermolysin;  (c) 
thermolytic  peptides  from  affinity  Sepha- 
rose-bound  proteins;  and  (d)  thermolytic 
peptides  from  control  Sepharose-bound 
proteins.  Arrowheads indicate positions of 
cAMP-binding fragments.  A  contaminating 
protein common to all patterns  is enriched 
for reference.  Values  (K)  indicate approxi- 
mate molecular weights of fragments. 
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ery and phosphorylation of wild-type R  were less than for 
mutant R. 
Since two-dimensional gel electrophoresis resolved forms 
of R  modified in charge by phosphorylation or mutation, it 
was  adopted  as  a  method  for identifying fragments  of R 
bearing modified residues. For the studies presented in this 
report, fragments were generated by proteolysis of native R 
with thermolysin or chymotrypsin and purified by cAMP- 
affinity chromatography. Two experimental protocols were 
used: in the first, R was digested in crude extracts of radiola- 
beled cells; and, in the second, radiolabeled R was digested 
after binding to an affinity column. The experiment of Fig. 2 
shows that specific R-derived fragments were generated by 
both of  these protocols. Fig 2, a and c shows two-dimensional 
gel patterns of thermolytic peptides bound by N~-(2-amino  - 
ethyl)-cAMP Sepharose from extracts of [35S]methionine-la- 
beled wild-type $49 cells; Fig. 2, b and d shows corresponding 
patterns of peptides bound by control Sepharose. For Fig. 2, 
a and b thermolysin was incubated with crude cell extracts, 
and  then  fragments  were  purified by  chromatography on 
affinity or control Sepharose columns. For Fig.  2,  c and d 
column-binding species  from a  crude cell extract were im- 
mobilized on affinity or control Sepharose, washed free of 
most contaminating cell proteins, and proteolyzed in place 
with thermolysin; columns were eluted after washing to re- 
move protease and unbound fragments. Thermolysin yielded 
a major cAMP-binding fragment of ~ 37 kdaltons and minor 
fragments of ~40.5, 33, 32.5, 30.2, and 16-18 kdaltons; when 
digestion was on column-bound R, almost all label was in the 
major 37-kdalton  peptide.  Patterns  of cAMP-binding chy- 
motryptic peptides from wild-type cell preparations are shown 
in Figs. 3 a, 4a, and 6 a; specifically-bound fragments (indi- 
cated by arrowheads) were identified with reference to control 
Sepharose-bound material as for Fig. 2 (data not shown). The 
major chymotryptic cAMP-binding fragment was a 33-kdal- 
ton species, and minor species of ~41.5, 32, and 28.5 kdaltons 
were also observed. When digestion was on column-bound R, 
chymotrypsin yielded, in addition, a prominent fragment of 
~38 kdaltons and several minor fragments between 28.5 and 
38 kdaltons (Fig. 6 a). Many of the larger fragments generated 
in crude cell extracts with either thermolysin or chymotrypsin 
formed doublets in the SDS gel dimension; the corresponding 
fragments  from  column-bound  R  were  single  species  that 
migrated with the larger forms generated in extracts.  This 
difference in fragment patterns from proteolyzed extracts and 
from  column-bound  R  suggested  that  many  of the  large 
fragments shared an end sensitive to a protease endogenous 
to $49 cell extracts. This suggestion  was confirmed (below, 
experiment of Fig.  6)  by  using  structural  mutations  that 
sensitized this end to proteolysis in the absence of exogenous 
proteases. 
Fig. 3 shows patterns of  cAMP-binding fragments generated 
from the  three sublines of $49  cells  whose R  patterns are 
shown in Fig.  l; digestions were performed in cell extracts 
with either chymotrypsin (Fig. 3, a-c) or thermolysin (Fig. 3, 
d-f).  Mutant forms of R  or its peptides are indicated with 
upward-pointing  arrowheads.  Patterns  from the  allelically- 
marked "wild-type" subline U36 (Fig.  3, b and e) were vir- 
tually identical to those  from the  wild-type subline  24.3.2 
(Fig.  3,  a  and  d) except for several minor high  molecular 
weight  peptides  that  had  counterparts  more  basic  by  ~2 
charge units (U) in the patterns from U36. The U36 electro- 
phoretic marker appeared to be within the 40.5- and 41.5- 
kdalton fragments generated, respectively, by thermolysin and 
chymotrypsin but outside the major 37-kdalton thermolytic 
fragment. In contrast to results with U36, all of the cAMP- 
binding fragments in wild-type cells had more basic counter- 
parts in peptide patterns from the Ka mutant subline U200.65 
(Fig. 3, c and f). 
Since the wild-type R  used for the experiments of Figs. 2 
and 3 was phosphorylated to an extent of ~90%, R fragments 
containing the phosphorylation site should have appeared in 
two forms differing in charge by 1 to 2 U with the more basic 
forms labeled to ~  10% the intensities of their more acidic 
counterparts. The major cAMP-binding fragments generated 
with thermolysin or chymotrypsin did not exhibit such charge 
heterogeneity (Figs. 2,  a  and c, 3, a  and d), but the minor 
41.5-kdalton chymotryptic fragment did (Fig. 3 a). In several 
experiments putative nonphosphorylated and phosphorylated 
forms of the 40.5-kdalton thermolytic fragment also could be 
distinguished (e.g., Fig. 2a). 3 Peptide patterns from U200.65 
(Fig. 3, c and f) provided further support for the presence of 
the phosphorylation site in the 41.5- and 40.5-kdalton frag- 
ments; reduced labeling of the phosphorylated form of wild- 
type R in this Ka mutant strain resulted in reduced labeling 
of the more acidic forms of wild-type 41.5- and 40.5-kdalton 
fragments (compare with patterns from U36 in Fig. 3, b and 
c). 
Fig.  4  compares patterns of cAMP-binding chymotryptic 
fragments from extracts of 32pi-labeled cells with those from 
extracts of [35S]methionine-labeled  cells to determine directly 
which  peptides  contain  the  phosphorylation site.  Fig.  4a 
shows  [35S]methionine-labeled  peptides, Fig.  4b shows  32pi- 
labeled peptides,  and  Fig.  4c shows  a  mixture of the two 
preparations. The ratio of 32p tO 35S cpm loaded onto gels was 
such  that  from  undigested  material  32pi-labeled R  gave  a 
stronger autoradiographic response than did [35S]methionine- 
labeled  R  (33).  In  the  chymotryptic peptide  patterns  32p~. 
labeling was restricted to undigested R and minor 48.5- and 
41.5-kdalton species  that also  labeled with [35S]methionine; 
the major 33-kdalton fragment from [35S]methionine-labeled 
R  was  not detected among peptides from 32pi-labeled R. A 
parallel experiment confirmed the absence of phosphate from 
the major 37-kdalton cAMP-binding fragment generated from 
R by proteolysis with thermolysin (not shown). 
To map sites of mutation and phosphorylation using the 
data of Figs. 3 and 4, it is necessary to know the positions of 
fragment endpoints in the  R  polypeptide chain.  Published 
reports have  localized cAMP-binding  regions of R  to  the 
carboxyterminal portion of the molecule (12, 42).  If cAMP- 
binding fragments actually contained the carboxyterminus of 
R, their molecular weights would estimate the positions of 
their aminoterminal  ends.  Fig.  5  shows  gel  patterns of Rs 
from U36 (Fig. 5 a) and from two Ka mutant sublines of U36 
that carry charge-shift mutations  in the wild-type allele  of 
U36. In U36.B1.R5 (Fig. 5 b) the mutation caused an acidic 
shift of 1 U in R, and in U36.B2.RI (Fig. 5c) the mutation 
caused an  acidic shift  of about  2  U  in  R.  In  addition  to 
3  Relative labeling of the putative nonphosphorylated form of the 
40.5-kdalton thermolytic peptide was less than expected from the R 
subunit pattern; this disproportion appears to reflect preferential 
production of the 40.5-kdalton peptide from kinase holoenzyme  and 
partitioning of most nonphosphorylated R in a "free" compartment 
(unpublished observations). 
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Cells  were  labeled  with  [3SS]methionine,  extracts  digested  with chymotrypsin or  thermolysin, and  cAMP-binding fragments 
purified by affinity chromatography as described  in Materials and Methods. 5 x  104 cpm from  the peptide preparations  were 
subjected  to two-dimensional gel electrophoresis, and autoradiograms  were exposed for 29 d. (a) Chymotryptic peptides from 
subline 24.3.2;  (b) chymotryptic  peptides from  subline U36; (c) chymotryptic peptides from  subline U200.65;  (d) thermolytic 
peptides from  subline 24.3.2;  (e) thermolytic peptides from  subline U36; and (f) thermolytic peptides from  subline U200.65. 
Arrowheads indicate positions of cAMP-binding peptides, with upward-pointing arrowheads specific for mutant forms. Molecular 
weights of some  of the fragments  are  indicated as in Fig. 2. Contaminating proteins common to the patterns  are  enclosed  in 
circles and diamonds. R indicates the position of undigested R. 
FIGURE 4  cAMP-binding chymotryptic  fragments  of  wild-type  R 
labeled with [3SS]methionine or 32p~. Chymotryptic fragments  were 
prepared  and  purified  from  extracts  of  cells  labeled  with  [35S]- 
methionine or 3zp~  as described in Materials and Methods. 2 x  104 
cpm of 3SS-labeled peptides and/or 103 cpm of 32P-labeled peptides 
were subjected  to two-dimensional gel electrophoresis, and auto- 
radiograms  were exposed  for  14  d  using  intensifying screens for 
gels  with  32P-labeled samples.  (a)  [35S]methionine~labe~ed frag- 
ments;  (b)  32P~-Iabeled fragments;  and  (c)  mixture of [~SS]methio- 
nine- and ~2P~-Iabeled  fragments.  Arrowheads indicate positions of 
R and its fragments;  diamonds enclose a contaminating protein in 
3SS-labeled samples. R and 33K indicate species corresponding to 
undigested  R and its major cAMP-binding chymotryptic fragment. 
altering  the  electrostatic  charge  of  R,  the  mutations  of 
U36.B1.R5 and U36.B2.R1  caused heterogeneity in the size 
of the K~  mutant  Rs.  The  proportion of Ka  mutant  R  in 
smaller forms varied between R preparations from the same 
strain, suggesting that the heterogeneity resulted from limited 
proteolysis during extraction and purification. This size het- 
erogeneity marks an end (or ends) of the mutant Rs and, as 
shown below, can be used to demonstrate that large cAMP- 
binding fragments of R contain its carboxyterminus. 
Fig. 6 shows two-dimensional gel patterns of chymotryptic 
fragments from column-bound R from sublines 24.3.2 (Fig. 
6a), U36 (Fig. 6b), U36.B1.R5 (Fig. 6c), or U36.B2.RI (Fig. 
6d).  Filled arrowheads indicate positions of wild-type pep- 
tides, upward-pointing open arrowheads indicate positions of 
peptides specific to the U36 marker allele product, and down- 
ward-pointing arrowheads indicate positions of peptides spe- 
cific to the Ka mutant Rs. Consistent with the results of the 
experiment of Fig. 3., charge heterogeneity attributable to the 
U36  marker allele mutation was  observed in  41.5-kdalton 
fragments, but not in 38-kdalton or smaller fragments. Acidic 
charge shifts attributable to the K~ mutations in U36.Bl.R5 
and U36.B2.R1 were found in the major 33-kdalton fragment 
and all larger fragments. Ka mutant forms of  the 38- and 41.5- 
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$49 subline U36 and two of its Ka 
mutant derivatives.  Rs were puri- 
fied from [35S]methionine-labeled 
cells  as  described  in  Materials 
and  Methods,  and  9,500  cpm 
from each sample were subjected 
to  two-dimensional gel  electro- 
phoresis.  Fluorographic  expo- 
sures were for 2 d. (a) R from sub- 
line  U36;  (b)  R  from  subline 
U36.B1 .R5; and (c) R from subline U36.B2.R1. Arrowheads indicate 
positions of Rs. 
kdalton fragments exhibited size heterogeneity similar to that 
seen in  the positions of their "undigested" R  counterparts, 
confirming that wild-type forms of these two fragments con- 
tained the same (carboxyterminal) end of R. (Fluorographic 
exposures longer than those shown in Fig. 6 clearly revealed 
mutant forms of  the 41.5-kdalton fragments.) The 33-kdalton 
fragments from the Ka mutant Rs were also heterogeneous in 
size, although relative labeling among the different forms was 
somewhat different from that of undigested mutant R. Since 
the U36 marker allele mutation fell within the 40.5-kdalton 
thermolytic  fragment  (Fig.  3)  but  outside  the  38-kdalton 
chymotryptic fragment (Fig. 6), carboxyterminal localization 
of the  38-kdalton fragment placed the mutation within an 
interval from ~8.5 to  11  kdaltons from the aminoterminus 
of R  (assuming that undigested R  is 49 kdaltons).  Patterns 
from the two Ka derivatives of U36, by resolving 38-kdalton 
fragments from the two R  allele products, also  proved that 
the 38-kdalton fragment from the U36 marker allele product 
had wild-type charge. Without this control, it remained pos- 
sible  that  the  absence  of charge  heterogeneity in  the  38- 
kdalton fragment from U36 reflected aberrant proteolysis of 
the mutant R. From the experiments of Figs. 2, 3, and 4, the 
endogenous phosphorylation site fell in the same fragments 
as did the U36 mutation. This result was also confirmed in 
the experiment of Figs. 5 and 6 by noting the effects of  the Ka 
mutations in U36.B 1.R5 and U36.B2.R 1 on labeling patterns 
of  the U36 marker allele product and its 38- and 41.5-kdalton 
peptides. 
Fig. 7 summarizes in diagrammatic form the results of the 
experiments presented in this report. Major cleavage sites for 
thermolysin (Th) and chymotrypsin (Ch) are shown in heavy 
arrows, and minor cleavage sites  are shown with lighter ar- 
rows. The region susceptible to endogenous proteolysis is also 
indicated (E). Sites of phosphorylation (ser-P) and mutation 
were localized to intervals delimited by the proteolytic cleav- 
age  sites.  For the  marker allele mutation  in  U36  and  the 
endogenous phosphorylation site,  localization was to an in- 
terval comprising  ~5%  of the  R  polypeptide. For the  K, 
mutations in U200.65, U36.B 1  .R5, and U36.B2.R 1, however, 
localization  was  only to  the  carboxyterminal 67%  of the 
molecule. Since two-dimensional gel electrophoresis provided 
information on both charge and size of R  fragments, it was 
possible to estimate net charge differences between fragments 
and, thereby, construct a map of charge density distribution 
for the protein. For the charge density histogram shown in 
Fig. 7, distances between fragments were calibrated for charge 
shifts using patterns from a variety of mutant sublines includ- 
ing, but not limited to, those shown in Figs. 3 and 6. Locations 
shown in Fig. 7 for structural domains implicated in R dimer 
formation (R~--~R), interaction between R and C (R~--~C), and 
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FIGURE 6  Chymotryptic fragments  of affinity  column-bound  Rs 
from wild-type and  mutant sublines  of $49.  Cyclic AMP-binding 
fragments  were prepared by chymotrypsin proteolysis  of affinity 
column-bound R from extracts of [35S]methionine-labeled cells as 
described in Materials and Methods. 3 x  104 cpm from the fragment 
preparations were subjected  to two-dimensional gel electrophore- 
sis, and fluorograms were exposed for 8 d. (a) Fragments from wild- 
type subline 24.3.2; (b) fragments from subline U36; (c) fragments 
from Ka mutant subline U36.B1  .R5; and (d) fragments from Ka mutant 
subline U36.B2.R1. Filled arrowheads and carets indicate positions 
of wild-type R fragments; upward-pointing open arrowheads indi- 
cate positions of fragments specific to the U36 marker allele  product 
and  downward-pointing open arrowheads indicate  positions of 
fragments specific to Ka mutant allele products. R and values (K) are 
used as in Figs. 2-4. 
cAMP-binding are based on published information (7, 8, 12- 
2 I). The allele marker mutation in U36 and the endogenous 
phosphorylation site  fell  at  the  aminoterminal  end  of the 
hinge-region between regions implicated in dimer formation 
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FIGURE 7  Map of chymotrypsin and thermolysin cleavage sites, sites of phosphorylation and  mutations,  and charge density 
distribution in $49 R. Arrows indicate the positions of chymotryptic cleavages (Ch) in column-bound R and thermolytic cleavages 
(Th) in R in crude cell extracts; major cleavage sites are indicated by the heavier arrows. Regions of R dimer interaction (R~,R) 
and of interaction of R with C (R<-*C) were inferred from published results as described  in the text. The histogram of charge 
density distribution was constructed  from data on charge differences  between R peptides;  mutations  were used to calibrate 
distances between peptides in isoelectric focusing dimensions of two-dimensional gel patterns. 
and binding of C. Three Ka mutations fell within the cAMP- 
binding domain of R, but they were not localized with great 
precision. 
DISCUSSION 
Type I R from $49 mouse lymphoma cells, like the homolo- 
gous proteins from other mammalian sources, has a proteo- 
lytically-stable cAMP-binding domain adjacent to a proteo- 
lytically-sensitive  hinge-region.  The  major  cAMP-binding 
thermolytic and chymotryptic fragments from $49  R  were 
similar in molecular weights to the corresponding fragments 
from purified porcine R~ (12,  14) except that the apparent 
values for $49  R  and its fragments were  ~6% greater than 
those reported for the porcine species; this small discrepancy 
is  probably  attributable  to  differences  in  gel  calibrations. 
Partial  amino  acid  sequences  are  available for the  regions 
surrounding the major thermolysin cleavage sites in porcine 
and bovine RlS (14, 20); data is more extensive for the bovine 
protein (20),  but,  where they overlap, the sequences are in 
complete agreement.  Among  the  eight  residues  aminoter- 
minal to the thermolysin cleavage site in bovine R~ are four 
arginines and a  lysine; the next  10 aminoterminal residues 
are neutral amino acids. A  similar very basic region to the 
aminoterminal side of the thermolysin cleavage site in $49 R 
can be deduced by the 5-charge unit-difference between the 
38-kdalton chymotryptic and 37-kdalton thermolytic cAMP- 
binding peptides (Fig.  7). Also in common with bovine and 
porcine R~s is that the region between endpoints of the 37- 
and 38-kdalton fragments from $49  cell  R  is susceptible to 
tryptic  cleavage  at  several  sites  (R.  A.  Steinberg  and  M. 
Stroczkowski, unpublished  results).  Three lines of evidence 
implicate this basic region in interactions of R with C: the C- 
inhibitory activity of R  is sensitive to the  arginine-specific 
reagent 2,3-butanedione (15); phosphorylation at a serine four 
residues carboxyterminal to the four arginines abolishes the 
C-inhibitory activity of R  (20,  21); and C protects this basic 
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region from tryptic digestion in partially-purified kinase hol- 
oenzyme (14).  C  also  appears to  protect  this  region  from 
proteolysis in $49 cell  R. Chymotryptic digestion of affinity 
column-bound  R  yielded  a  prominent  38-kdalton  cAMP- 
binding fragment (Fig. 6) that was absent from digests of cell 
extracts (Figs.  3 and 4).  Thermolysin digestion of partially- 
purified kinase  holoenzyme from $49  cells yielded the  37- 
kdalton fragment seen in the experiments of Figs.  2  and  3 
only when cAMP was present during digestion; in the absence 
of cAMP, the major product was the 40.5-kdalton fragment 
produced as a minor species in digests of crude extracts (Figs. 
2 and 3; R. A. Steinberg, unpublished results).  It is not clear 
why purification was needed to reveal protection of the ther- 
molysin site but not that of the chymotrypsin site. 
Immediately carboxyterminal to the basic region discussed 
above is a  region delimited by the  major cleavage sites for 
thermolysin  and  chymotrypsin that  carries  a  net  negative 
charge of 4  U  (Fig.  7).  In the  hinge-region sequence  from 
bovine R] (20), there are 14 residues between the site cleaved 
by thermolysin and  a  tyr-val bond  that  appears to  be the 
major cleavage site for chymotrypsin (l 4);  4 this interval con- 
tains four acidic residues and no basic residues. This 14 amino 
acid interval is grossly overestimated in size by the differences 
in SDS mobilities of carboxyterminal thermolytic and chy- 
motryptic fragments from porcine R~, and, presumably, from 
$49 R as well. The acidic region extending from ~  12 to  16 
kdaltons from the aminoterminus of R in the map of Fig. 7, 
therefore, actually comprises only ~  1,500 daltons of protein. 
When sequence data is available for the entire protein, similar 
corrections may have to be applied to additional regions of 
4  The aminoterminal sequence of the carboxyterminal chymotryptic 
fragment from porcine R differed in two residues from the sequence 
carboxyterminal to the proposed chymotrypsin cleavage site in the 
bovine sequence; both changes could have resulted from single base 
substitutions in the gene sequence. the $49 R~ map. An acidic region occupies a position in the 
bovine Rn sequence equivalent to that of the acidic region in 
bovine and $49 R~s; it has been argued that, along with the 
arginine-rich region discussed above, this acidic region may 
be important for the interaction of R with C (40). 
In contrast to the autophosphorylation site in Rn (13, 15, 
42) and the site in RI phosphorylated by cGMP-dependent 
protein kinase (20), the endogenous phosphoserine in $49 R 
is aminoterminal to the major cleavage sites for both chy- 
motrypsin and thermolysin. The endogenous phosphorylation 
site in $49 cell R  and the allele marker mutation in subline 
U36  map to the aminoterminal end of the hinge-region at 
10 kdaltons from the aminoterminus of R  or in about the 
position of the site in Rn phosphorylated by casein kinase II 
(22,  23). The location of the endogenous phosphoserine near 
the region implicated in R-C interaction is consistent with a 
catalytic role of C in R~ phosphorylation; such a role, in turn, 
is consistent with the marked reduction in R phosphorylation 
observed in $49 cell mutants deficient in C activity (32,  33). 
Nevertheless, it has not been possible to demonstrate phos- 
phorylation  of R  by C  in  purified  preparations  of type  I 
protein kinase (3,  19, 43).  Despite its close proximity to the 
site of endogenous phosphorylation, the marker allele muta- 
tion in subline U36 has little or no effect on R phosphoryla- 
tion (Figs.  1 and 5). 
Although the charge changes caused by the U36 mutation 
or endogenous phosphorylation might be expected to alter 
the local configuration of R, neither modification has a dis- 
cernible effect on the activation parameters ofkinase (21, 32). 
This suggests  that the aminoterminal portion  of the hinge- 
region is not involved in binding or inhibition of C. On the 
other  hand,  three  different Ka  mutations that  increase the 
apparent constant for activation of $49 kinase by cAMP map 
within the carboxyterminal cAMP-binding region of R; more 
refined mapping of these and 22 additional charge-shift/Ca 
mutations has localized them all to a  few sites in  a  region 
from ~7 to 25 kdaltons from the carboxyterminus of R (R. 
A. Steinberg, submitted manuscripts; and R. A. Steinberg and 
E.  F.  McHugh,  unpublished  results).  Thus, despite the sug- 
gestion that some/Ca mutations primarily affect interactions 
between R  and C (31),  none of those we have mapped falls 
near the region thought to be important in these interactions. 
/Ca mutants are heterozygous for expression of mutant and 
wild-type R  alleles  (24,  44,  and this  report),  yet <25%  of 
kinase from Ka mutant cells has wild-type activation param- 
eters (44,  45).  This dominance of the mutant allele product 
appears to be explained in part by its modification of wild- 
type R  properties through heterodimer formation (45).  If R 
dimer interaction  is  limited to the  aminoterminal domain 
implicated by proteolysis studies (14), the ability of/Ca muta- 
tions in the carboxyterminal half of R to affect properties of 
wild-type  R  through  heterodimer  formation  suggests  that 
there is significant conformational interaction between ami- 
noterminal and carboxyterminal domains and between mon- 
omers linked through dimer association. Alternatively, there 
may be additional dimer interaction regions in the carboxy- 
terminus of R.  In this  regard,  it is interesting to note that 
considerable homology has been found between cAMP-bind- 
ing site sequences in bovine Rn and  in the catabolite gene 
activator protein ofEscherichia coli (46); in the E. coli protein, 
cAMP-binding sites are formed by interactions of sequences 
from both monomers of the dimeric protein (47). 
Two-dimensional partial proteolysis peptide maps have the 
potential for providing a  rapid and inexpensive method for 
mapping mutations in  R~ and  for comparing R~  structures 
from various animal species. In the studies presented in this 
report, cAMP-binding fragments from native  R  have been 
used to localize mutations to major structural domains of the 
protein. For high resolution mapping using partial proteolytic 
digests,  it is important to introduce a large number of cleav- 
ages within relatively small regions of the protein. The frag- 
ments used in the present studies allow mapping of features 
within the hinge-region of R  to intervals comprising 5% or 
less of the R polypeptide chain. To achieve comparable map- 
ping of mutations within the cAMP-binding carboxyterminus 
of the protein, it has been necessary to generate proteolytic 
fragments from denatured  R.  In  subsequent  reports  I  will 
present experiments that map endpoints of fragments gener- 
ated from denatured R and map mutations to intervals delim- 
ited by these fragment endpoints (R. A. Steinberg, submitted 
manuscripts). 
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